EICHORCondition: Musculoskeletal Disorder · Anxiety Disorders · Depression · Sponsor: Nordlandssykehuset HF
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The Norwegian Sickness Absence Clinic (NSAC) is a publicly funded specialist outpatient health service, which is uniquely available for the work force. The overall aim of the NSAC is prevention of sickness absence, promote return to work (RTW) among those on sickness absence and prevent long term disability benefit dependency. In addition to being a health service, the NSAC has a focus on work and functional recovery, including also non-health related factors. Patients can be referred by general practitioners for mental health problems and musculoskeletal problems. The NSAC has a lower threshold for severity than specialist health services generally, and in particular for mental health problems. The efficacy of this service is unknown. The NSAC Efficacy Study is a randomized controlled multicentre trial which aims to assess the effect of the NSAC service. "Helse i Arbeid" is the Norwegian name for NSAC, and the Norwegian abbreviation is "HiA". The Norwegian study name is HIANOR. The NSAC Efficacy Study involves five different NSACs across northern Norway, and will recruit 2500 patients, randomized to in equal proportions to three treatment arms: 1. NSAC - rapid: treatment at the NSAC at- or within 4 weeks 2. NSAC - ordinary: treatment at the NSAC after 10-14 weeks 3. NSAC - active control: monodisciplinary examination at the NSAC close to diagnosis-specific deadline for examination as suggested by guidelines (8-26 weeks, the majority at the end of this interval) The overal…
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: \* The patient must be considered eligible for treatment at the NSAC by the admission team at the NSAC. Exclusion Criteria: * Patients considered too healthy for treatment at the NSAC, i.e. not within target group * Patients considered too sick for treatment at the NSAC, i.e. not within target group * Patients that do not have a diagnosis that is relevant for treatment at the NSAC, i.e. not within target group * Patients otherwise considered not within target group for the measure * Patients which were included in the NSAC Nudge trial (clinicaltrials identifier: NCT05006976) may not be recruited within the first year of follow-up of that trial * Patients which are secondary referred from other departments/clinics within the hospital * Non-Norwegian or non-English speaking patients * Patients which could not be reached by the research coordinator at the outpatient clinic for information about the study
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Helse I Arbeid Nordlandssykehuset | Bodø, Nordland, Norway | — |
| Helse I Arbeid Helgelandssykehuset | Sandnessjøen, Nordland, Norway | — |
| Helsepartner Rehabilitering Alta | Alta, Troms Og Finnmark, Norway | — |
| Helse I Arbeid Finnmarkssykehuset | Kirkenes, Troms Og Finnmark, Norway | — |
| Helse I Arbeid Universitetssykehuset Nord-Norge | Tromsø, Troms Og Finnmark, Norway | — |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05310695